Authors:
Kollmannsberger, C
Gerl, A
Schleucher, N
Beyer, J
Kuczyk, M
Rick, O
Gasper, J
Sosada, M
Rie, C
Kanz, L
Bokemeyer, C
Citation: C. Kollmannsberger et al., Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancer, ANTI-CANC D, 11(7), 2000, pp. 535-539
Authors:
Hartmann, JT
Knop, S
Fels, LM
van Vangerow, A
Stolte, H
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors, ANTI-CANC D, 11(1), 2000, pp. 1-6
Authors:
Kollmannsberger, C
Nichols, C
Meisner, C
Mayer, F
Kanz, L
Bokemeyer, C
Citation: C. Kollmannsberger et al., Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: An explorative analysis using cart modeling, ANN ONCOL, 11(9), 2000, pp. 1115-1120
Authors:
Kollmannsberger, C
Nichols, C
Bamberg, M
Hartmann, JT
Schleucher, N
Beyer, J
Schoffski, P
Derigs, G
Ruther, U
Bohlke, I
Schmoll, HJ
Kanz, L
Bokemeyer, C
Citation: C. Kollmannsberger et al., First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases, ANN ONCOL, 11(5), 2000, pp. 553-559
Authors:
Gunaydin, I
Pereira, PL
Daikeler, T
Mohren, M
Trubenbach, J
Schick, F
Kanz, L
Kotter, I
Citation: I. Gunaydin et al., Magnetic resonance imaging guided corticosteroid injection of the sacroiliac joints in patients with therapy resistant spondyloarthropathy: A pilot study, J RHEUMATOL, 27(2), 2000, pp. 424-428
Citation: F. Bautz et al., Expression and secretion of vascular endothelial growth factor-A by cytokine-stimulated hematopoietic progenitor cells: Possible role in the hematopoietic microenvironment, EXP HEMATOL, 28(6), 2000, pp. 700-706
Authors:
Kratz-Albers, K
Scheding, S
Mohle, R
Buhring, HJ
Baum, CM
Mc Kearn, JP
Buchner, T
Kanz, L
Brugger, W
Citation: K. Kratz-albers et al., Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin, EXP HEMATOL, 28(3), 2000, pp. 335-346
Authors:
Schafer, H
Bader, P
Kaiserling, E
Klingebiel, T
Handgretinger, R
Kanz, L
Einsele, H
Citation: H. Schafer et al., Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation, BONE MAR TR, 26(10), 2000, pp. 1133-1134
Authors:
Einsele, H
Hebart, H
Kauffman-Schneider, C
Sinzger, C
Jahn, G
Bader, P
Klingebiel, T
Dietz, K
Loffler, J
Bokemeyer, C
Muller, CA
Kanz, L
Citation: H. Einsele et al., Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection, BONE MAR TR, 25(7), 2000, pp. 757-763
Authors:
Hartmann, JT
Fels, LM
Franzke, A
Knop, S
Renn, M
Maess, B
Panagiotou, P
Lampe, H
Kanz, L
Stolte, H
Bokemeyer, C
Citation: Jt. Hartmann et al., Comparative study of the acute nephrotoxicity from standard dose cisplatin+/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide, ANTICANC R, 20(5C), 2000, pp. 3767-3773
Citation: Jt. Hartmann et al., Phase II study of continuous 120-hour- infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma, ANTICANC R, 20(2B), 2000, pp. 1177-1182
Authors:
Hartmann, JT
Fels, LM
Knop, S
Stolte, H
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors, INV NEW DR, 18(3), 2000, pp. 281-289
Authors:
Braun, N
Faul, C
Wernet, D
Schnaidt, M
Stuhler, G
Kanz, L
Risler, T
Einsele, H
Citation: N. Braun et al., Successful transplantation of highly selected CD34+peripheral blood stem cells in a HLA-sensitized patient treated with immunoadsorption onto proteinA, TRANSPLANT, 69(8), 2000, pp. 1742-1744
Authors:
Machann, J
Pereira, PL
Einsele, H
Kanz, L
Claussen, CD
Schick, F
Citation: J. Machann et al., MR Characterization of the hemapoetic bone marrow. Findings in generalizedneoplasia and treatment monitoring, RADIOLOGE, 40(8), 2000, pp. 700-709
Authors:
Hebart, H
Loffler, J
Meisner, C
Serey, F
Schmidt, D
Bohme, A
Martin, H
Engel, A
Bunjes, D
Kern, WV
Schumacher, U
Kanz, L
Einsele, H
Citation: H. Hebart et al., Early detection of Aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening, J INFEC DIS, 181(5), 2000, pp. 1713-1719
Authors:
Brossart, P
Zobywalski, A
Grunebach, F
Behnke, L
Stuhler, G
Reichardt, VL
Kanz, L
Brugger, W
Citation: P. Brossart et al., Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells, CANCER RES, 60(16), 2000, pp. 4485-4492
Authors:
Hartmann, JT
Nichols, CR
Droz, JP
Horwich, A
Gerl, A
Fossa, SD
Beyer, J
Pont, J
Einhorn, L
Kanz, L
Bokemeyer, C
Citation: Jt. Hartmann et al., The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors, CANCER, 88(11), 2000, pp. 2629-2635
Authors:
Hebart, H
Loffler, J
Reitze, H
Engel, A
Schumacher, U
Klingebiel, T
Bader, P
Bohme, A
Martin, H
Bunjes, D
Kern, WV
Kanz, L
Einsele, H
Citation: H. Hebart et al., Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia, BR J HAEM, 111(2), 2000, pp. 635-640
Authors:
Mohle, R
Schittenhelm, M
Failenschmid, C
Bautz, F
Kratz-Albers, K
Serve, H
Brugger, W
Kanz, L
Citation: R. Mohle et al., Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia, BR J HAEM, 110(3), 2000, pp. 563-572
Authors:
Beck, R
Neipel, F
Canji, B
Hebart, H
Kanz, L
Jahn, G
Einsele, H
Citation: R. Beck et al., Absence of human herpesvirus 8 DNA sequences in leucapheresis products andbone marrow samples of patients with advanced multiple myeloma, BR J HAEM, 109(3), 2000, pp. 676-677